PMC:7536913 / 4679-4859
Annnotations
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T26 | 21-28 | http://www.ebi.ac.uk/efo/EFO_0000881 | denotes | digital |
| T27 | 101-102 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T28 | 126-127 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T6 | 163-167 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 54 | 50-58 | Species | denotes | patients | Tax:9606 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T34 | 0-180 | Sentence | denotes | By utilizing various digital health technologies, patients can participate in one or more aspects of a trial without visiting a clinical site as part of “routine” drug development. |